Early prediction of anthracycline induced cardiotoxicity. - Wikidata - wikimedia - TriplyDB

Early prediction of anthracycline induced cardiotoxicity.

Early prediction of anthracycline induced cardiotoxicity.

http://www.wikidata.org/entity/Q48226302

about

The Role of Biomarkers in Decreasing Risk of Cardiac Toxicity after Cancer Therapy Exercise Prevention of Cardiovascular Disease in Breast Cancer Survivors Use of biomarkers for the assessment of chemotherapy-induced cardiac toxicity.Assessment of cardiotoxicity with cardiac biomarkers in cancer patients.Managing chemotherapy-related cardiotoxicity in survivors of childhood cancers.Utilizing cardiac biomarkers to detect and prevent chemotherapy-induced cardiomyopathy.Troponin in hematologic oncology.The role of biomarkers in the early detection of anthracycline-induced cardiotoxicity in children: a review of the literature.Late effects of childhood leukemia therapy.Role of biomarkers in cardioncology.Using cardiac biomarkers and treating cardiotoxicity in cancer.Bedside biomarkers in pediatric cardio renal injuries in emergency.New biomarkers for early detection of cardiotoxicity after treatment with docetaxel, doxorubicin and cyclophosphamide.Cardiac complications of chemotherapy: role of biomarkers.

P2860

Q26743433-F8746378-69E8-41FF-8313-23735234D79E Q26785410-A95EAAF0-751C-4A8E-83B2-544F11133BDB Q27027354-326523B9-D2F9-4FFE-99ED-868B0BAE6C20 Q33896047-C676B8B0-A620-4E6A-B188-6F94CDC5EEFA Q35562745-84BAE0D1-A041-4641-8ED2-B753D563C10C Q35588736-92D5C0B5-4D0E-4A0A-A516-028155EDE96B Q37071685-9927386C-2D23-41B1-A0B5-AB7C230AED32 Q37292501-4D607C2F-3E95-426B-A7A1-0E23F55E5A8A Q37892981-2E62C2D1-1696-4A09-AC83-996A4B9DC3FC Q37926595-D734A5A1-C399-4F6C-BD4E-A05AC69D86E8 Q38069202-CEB24DBA-E2F0-40D7-B7DF-193909F80103 Q38261952-85594C46-3D8B-46AE-A863-D05D455EA5AE Q39005990-8F47B36C-F694-4BA6-929F-5CE4E8F7FCFC Q51739297-B1BE9A4C-42D2-491D-8A4A-357CFD2A4220

P2860

Early prediction of anthracycline induced cardiotoxicity.

http://www.wikidata.org/entity/Q48226302

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Early prediction of anthracycline induced cardiotoxicity.

@en

Early prediction of anthracycline induced cardiotoxicity.

@nl

type

label

Early prediction of anthracycline induced cardiotoxicity.

@en

Early prediction of anthracycline induced cardiotoxicity.

@nl

prefLabel

Early prediction of anthracycline induced cardiotoxicity.

@en

Early prediction of anthracycline induced cardiotoxicity.

@nl

P1433

Q48226302-F0042C39-F2E6-4A15-8EA3-713D3C1A9744

P1476

Q48226302-F767E403-6C12-43C9-B2D0-AD0237673FCC

P2093

Q48226302-03CBC297-A387-46C8-9910-193A4743220C

Q48226302-1DCD09EF-2351-40AA-A375-826C410F5404

Q48226302-627D6C76-5F6A-4E60-8583-9E5D1E728226

Q48226302-7152C7DA-0B61-4E59-A2AC-92CCC24B0CAA

Q48226302-DAFD5BCC-31F7-4506-8417-33868B42E9CF

Q48226302-EAD7387E-5C42-432D-A803-1DC7B2FF27DF

P2860

Q48226302-2B633D0A-4ADB-48ED-B413-7E6140119EF8

Q48226302-41811043-FAB7-467B-9B19-C2A4C6BB8AB4

Q48226302-4FB1C671-C96A-42A3-B5B5-85DDE06DB608

Q48226302-51C98BD1-EBF5-454E-B11D-AD24791F46C2

Q48226302-56B69C5A-81D1-4449-BD9E-FCEC7CD30BBE

Q48226302-74B92336-0D5B-4A92-89B5-65CD7D0B9316

Q48226302-74E51149-0166-413D-BC09-E087B7FE2D1D

Q48226302-75872B3E-93BA-4B3C-982E-D106282A893D

Q48226302-853FE06D-6AB5-44FA-AF4E-5FC5AF5B840D

Q48226302-CB95DE7F-792E-40B9-8DA6-AE6A55D8BF63

P304

Q48226302-18A6F6BF-2500-49EC-AD58-860D8FB4BA46

P31

Q48226302-960AFE11-3C6E-4039-A11D-DDA43517CA4F

P356

Q48226302-29471E2D-1C25-4983-8452-D2ADF991AE5C

P407

Q48226302-86C35B88-C280-4F32-8CB3-ACFE258E1CDA

P433

Q48226302-0C41BB49-AE42-48E2-B84C-0E367AF3A2F4

P478

Q48226302-1427F504-626B-4A38-ABBA-DF2AC57CA399

P577

Q48226302-CEB65CD8-5D4F-46B6-AEA3-283F8B608C03

P698

Q48226302-7A17F2D5-A930-4D6A-ACF1-B43A56D228C8

P356

J.1651-2227.2006.00174.X

P1433

Acta Paediatrica

P1476

Early prediction of anthracycline induced cardiotoxicity.

@en

P2093

Aysegul Akbay Yarpuzlu

http://www.w3.org/2001/XMLSchema#string

Bedirhan Erkus

http://www.w3.org/2001/XMLSchema#string

Levent Karaca

http://www.w3.org/2001/XMLSchema#string

Murat Can

http://www.w3.org/2001/XMLSchema#string

Selda Demirtas

http://www.w3.org/2001/XMLSchema#string

Yasemin Genc

http://www.w3.org/2001/XMLSchema#string

P2860

Risk factors for doxorubicin-induced congestive heart failure

Cardiac troponin I and troponin T: recent players in the field of myocardial markers.

Anthracyclines and the heart.

Subcellular effects of adriamycin in the heart: a concise review.

Cardiac troponin I and troponin T: are enzymes still relevant as cardiac markers?

Brain natriuretic peptide is a predictor of anthracycline-induced cardiotoxicity.

Functional monitoring of anthracycline cardiotoxicity: a prospective, blinded, long-term observational study of outcome in 120 patients.

Serum troponin T levels and echocardiographic evaluation in children treated with doxorubicin.

Elevated B-type natriuretic peptide levels after anthracycline administration.

Plasma brain natriuretic peptide measured by fully-automated immunoassay and by immunoradiometric assay compared.

P304

506-509

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1651-2227.2006.00174.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

96

http://www.w3.org/2001/XMLSchema#string

P577

2007-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17391467

http://www.w3.org/2001/XMLSchema#string